Upgrade to SI Premium - Free Trial

IBM (IBM) Reiterated at Buy by Stifel After $2B Chips Act Distribution Announced

May 22, 2026 7:13 AM
Stifel analyst David Grossman reiterated a Buy rating and $290.00 price target on IBM (NYSE: IBM).The analyst commented, "the US ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments